Overview

An Evaluation of Weekly Tafenoquine

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This was a placebo controlled, randomised, double-blind, double-dummy study of the efficacy of weekly tafenoquine compared with weekly mefloquine or placebo in the chemosuppression of P. falciparum in Nyanza Province, western Kenya.
Phase:
Phase 2
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command
Collaborator:
SmithKline Beecham
Treatments:
Mefloquine
Tafenoquine